Search Results

Lecanemab: First Approval.

• Authors : Hoy SM; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy; Humans ; Amyloid beta-Peptides

• Source: Drugs [Drugs] 2023 Mar; Vol. 83 (4), pp. 359-365.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.

• Authors : Gupta AK; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Mediprobe Research Inc, London, Ontario, Canada.

Subjects: Onychomycosis*/Onychomycosis*/Onychomycosis*/drug therapy ; Foot Dermatoses*/Foot Dermatoses*/Foot Dermatoses*/drug therapy ; Dermatologic Agents*/Dermatologic Agents*/Dermatologic Agents*/therapeutic use

• Source: International journal of dermatology [Int J Dermatol] 2022 Dec; Vol. 61 (12), pp. 1431-1441. Date of Electronic Publication: 2021 Dec 09.Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The next chapter in Alzheimer's disease treatment: Antiamyloid monoclonal antibodies.

• Authors : Theroux JD; Marino AB; Drake ES

• Source: The Nurse practitioner [Nurse Pract] 2024 Nov 01; Vol. 49 (11), pp. 16-21. Date of Electronic Publication: 2024 Oct 29.Publisher: Springhouse Corp Country of Publication: United States NLM ID: 7603663 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.

• Authors : Nishimura T; Department of Next-generation Clinical Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Velaga R

• Source: Cancer science [Cancer Sci] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.

• Authors : Wyatt NJ; Faculty of Medical Sciences, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, UK.

Subjects: Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/drug therapy; Antibodies, Monoclonal ; Humans

• Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2021 Sep; Vol. 35 (5), pp. 473-503. Date of Electronic Publication: 2021 Oct 06.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor.

• Authors : Nomoto M; Eisai Co., Ltd., Tokyo, Japan.; Hasunuma T

• Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Aug 01. Date of Electronic Publication: 2024 Aug 01.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.

• Authors : Kimura G; Department of Urology, Nippon Medical School Hospital, Tokyo, Japan.; Fujii Y

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/drug therapy ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/psychology ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/therapy

• Source: Cancer medicine [Cancer Med] 2024 Jun; Vol. 13 (11), pp. e7196.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited

Record details

Aducanumab: First Approval.

• Authors : Dhillon S; Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. .

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*antagonists & inhibitors ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use

• Source: Drugs [Drugs] 2021 Aug; Vol. 81 (12), pp. 1437-1443.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring.

• Authors : Franco V; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.; IRCCS Mondino Foundation, Pavia, Italy.

Subjects: Anticonvulsants/Anticonvulsants/Anticonvulsants/*blood ; Dried Blood Spot Testing/Dried Blood Spot Testing/Dried Blood Spot Testing/*methods ; Drug Monitoring/Drug Monitoring/Drug Monitoring/*methods

• Source: Therapeutic drug monitoring [Ther Drug Monit] 2020 Apr; Vol. 42 (2), pp. 309-314.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Association between pre-treatment computed tomography findings and post-treatment persistent decrease in lung perfusion blood volume.

• Authors : Hirata T; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata-City, Niigata, 951-8510, Japan. .; Yoshimura N

Subjects: Pulmonary Embolism*/Pulmonary Embolism*/Pulmonary Embolism*/diagnostic imaging ; Blood Volume* ; Lung*/Lung*/Lung*/diagnostic imaging

• Source: Scientific reports [Sci Rep] 2024 May 24; Vol. 14 (1), pp. 11919. Date of Electronic Publication: 2024 May 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details